Brucelosis

Centers for Disease Control and Prevention. Brucellosis reference guide: exposures, testing and prevention. Feb 2017 [internet publication].Texto completo

World Health Organization. Brucellosis in humans and animals. 2006 [internet publication].Texto completo

Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, et al. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007179.Texto completo  Resumen

1. Madkour MM. Madkour's brucellosis. 2nd ed. New York, NY: Springer-Verlag; 2001.

2. Pappas G, Akritidis N, Bosilkovski M, et al. Brucellosis. N Engl J Med. 2005 Jun 2;352(22):2325-36.. Resumen

3. Hasanjani Roushan MR, Moherez M, Smailnejad Gangi S, et al. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect. 2004 Dec;132(6):1109-14. Resumen

4. Andriopoulos P, Tsironi M, Deftereos S, et al. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007 Jan;11(1):52-7.Texto completo  Resumen

5. Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006 Feb;6(2):91-9. Resumen

6. Mor SM, Wiethoelter AK, Massey PD, et al. Pigs, pooches and pasteurisation: The changing face of brucellosis in Australia. Aust J Gen Pract. 2018 Mar;47(3):99-103.Texto completo  Resumen

7. Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995 Aug;21(2):283-9. Resumen

8. Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S8-11. Resumen

9. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007 Jul;25(3):188-202. Resumen

10. Gwida M, Al Dahouk S, Melzer F, et al. Brucellosis - regionally emerging zoonotic disease? Croat Med J. 2010 Aug;51(4):289-95.Texto completo  Resumen

11. Campbell JI, Lan NPH, Phuong PM, et al. Human Brucella melitensis infections in southern Vietnam. Clin Microbiol Infect. 2017 Nov;23(11):788-90.Texto completo  Resumen

12. Guerrier G, Daronat JM, Morisse L, et al. Epidemiological and clinical aspects of human Brucella suis infection in Polynesia. Epidemiol Infect. 2011 Oct;139(10):1621-5. Resumen

13. Ekpanyaskul C, Santiwattanakul S, Tantisiriwat W, et al. Factors associated with seropositive antibodies to Brucella melitensis in the Nakhon Nayok, Thailand. J Med Assoc Thai. 2012 Dec;95(suppl 12):S40-6 Resumen

14. Lewis JM, Folb J, Kalra S, et al. Brucella melitensis prosthetic joint infection in a traveller returning to the UK from Thailand: case report and review of the literature. Travel Med Infect Dis. 2016 Sep - Oct;14(5):444-50.Texto completo  Resumen

15. Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005 May-Jun;36(3):313-26.Texto completo  Resumen

16. Zinsstag J, Schelling S, Wyss K, et al. Potential of cooperation between human and animal health to strengthen health systems. Lancet. 2005 Dec 17;366(9503):2142-5. Resumen

17. Kunda J, Fitzpatrick J, Kazwala R, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health. 2007 Nov 3;7:315.Texto completo  Resumen

18. Dean AS, Crump L, Greter H, et al. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6(10):e1865.Texto completo  Resumen

19. Almuneef MA, Memish ZA, Balkhy HH, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect. 2004 Jun;132(3):533-40. Resumen

20. Mendoza-Núñez M, Mulder M, Franco MP, et al. Brucellosis in household members of Brucella patients residing in a large urban setting in Peru. Am J Trop Med Hyg. 2008 Apr;78(4):595-8. Resumen

21. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med. 2004 Jan-Feb;11(1):49-55. Resumen

22. Dahouk SA, Neubauer H, Hensel A, et al. Changing epidemiology of human brucellosis, Germany, 1962-2005. Emerg Infect Dis. 2007 Dec;13(12):1895-900.Texto completo  Resumen

23. Australian Government Department of Health. National Notifiable Diseases Surveillance System. Notifications of a selected disease by month and year, 1991 to present. Brucellosis. Sep 2022 [internet publication].Texto completo

24. Centers for Disease Control and Prevention. National notifiable infectious diseases tables. May 2025 [internet publication].Texto completo

25. Centers for Disease Control and Prevention. CDC and Texas health officials warn about illness linked to raw milk from Texas dairy. September 2017 [internet publication].Texto completo

26. Cossaboom CM, Kharod GA, Salzer JS, et al. Notes from the field: brucella abortus vaccine strain RB51 infection and exposures associated with raw milk consumption - Wise County, Texas, 2017. MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):286.Texto completo  Resumen

27. Centers for Disease Control and Prevention. People in four states may be drinking contaminated raw milk. Nov 2017 [internet publication].Texto completo

28. Centers for Disease Control and Prevention. Health Alert Network (HAN). Third case of rifampin/penicillin-resistant strain of RB51 brucella from consuming raw milk. Jan 2019 [internet publication].Texto completo

29. Mia MM, Hasan M, Pory FS. Occupational exposure to livestock and risk of tuberculosis and brucellosis: a systematic review and meta-analysis. One Health. 2022 Dec;15:100432.Texto completo  Resumen

30. Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976 Apr;13(2):105-14. Resumen

31. Harding AL, Byers KB. Epidemiology of laboratory-associated infections. In: Fleming DO, Hunt DL, eds. Biological safety: principles and practices. 3rd ed. Washington, DC: ASM Press; 2000:35-6.

32. Ergonul O, Celikbas A, Tezeren D, et al. Analysis of risk factors for laboratory-acquired Brucella infections. J Hosp Infect. 2004 Mar;56(3):223-7. Resumen

33. Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis. 2005 Aug;11(8):1180-5. Resumen

34. Bouza E, Sanchez-Carrillo C, Hernangomez S, et al. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect. 2005 Sep;61(1):80-3. Resumen

35. Centers for Disease Control and Prevention (CDC). Laboratory-acquired brucellosis - Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep. 2008 Jan 18;57(2):39-42.Texto completo  Resumen

36. Reddy S, Manuel R, Sheridan E, et al. Brucellosis in the United Kingdom - a risk to laboratory workers? Recommendations for prevention and management of laboratory exposure. J Clin Pathol. 2010 Jan;63(1):90-2. Resumen

37. Knudsen A, Kronborg G, Dahl Knudsen J, et al. Laboratory exposure to Brucella melitensis in Denmark: a prospective study. J Hosp Infect. 2013 Nov;85(3):237-9. Resumen

38. Traxler RM, Lehman MW, Bosserman EA, et al. A literature review of laboratory-acquired brucellosis. J Clin Microbiol. 2013 Sep;51(9):3055-62.Texto completo  Resumen

39. Estagnasié C, Surgers L, Berdugo K, et al. Recurrence of brucellosis on breast implants. Infect Dis Now. 2023 Mar;53(2):104644.Texto completo  Resumen

40. Pereira CR, Cotrim de Almeida JVF, Cardoso de Oliveira IR, et al. Occupational exposure to Brucella spp.: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2020 May;14(5):e0008164.Texto completo  Resumen

41. Beeching NJ. Brucellosis. In Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison’s principles of internal medicine. 20th ed. New York, NY: McGraw-Hill; 2018:1192-6.

42. Beeching NJ, Madkour MM. Brucellosis. In: Farrar J, Hotez P, Junghanss T, et al, eds. Manson’s tropical diseases. 23rd ed. London: Elsevier; 2013:371-378, 378.e1.

43. De BK, Stauffer L, Koylass MS, et al. Novel Brucella strain (BO1) associated with a prosthetic breast implant infection. J Clin Microbiol. 2008 Jan;46(1):43-9.Texto completo  Resumen

44. Scholz HC, Nöckler K, Göllner C, et al. Brucella inopinata sp. nov., isolated from a breast implant infection. Int J Syst Evol Microbiol. 2010 Apr;60(Pt 4):801-8.Texto completo  Resumen

45. Jiménez de Bagüés MP, Iturralde M, Arias MA, et al. The new strains Brucella inopinata BO1 and Brucella species 83-210 behave biologically like classic infectious Brucella species and cause death in murine models of infection. J Infect Dis. 2014 Aug 1;210(3):467-72.Texto completo  Resumen

46. Sabbaghian H. Fresh white cheese as a cause of Brucella infection. Public Health. 1975 May;89(4):165-9. Resumen

47. Entessar F, Ardalan A. Brucella. Geneva: World Health Organization; 1964.

48. Beeching NJ, Erdem H. Brucellosis. In: Cohen J, Powderly WG, Opal SM, eds. Infectious diseases. 4th ed. London: Elsevier Science; 2016:1098-1101.

49. Langer AJ, Ayers T, Grass J, et al. Nonpasteurized dairy products, disease outbreaks, and state laws - United States, 1993-2006. Emerg Infect Dis. 2012 Mar;18(3):385-91.Texto completo  Resumen

50. Claeys WL, Cardoen S, Daube G, et al. Raw or heated cow milk consumption: review of risks and benefits. Food Control. 2013;31:251-62.

51. Guihot A, Bossi P, Bricaire F. Bioterrorism with brucellosis [in French]. Presse Med. 2004 Jan 31;33(2):119-22. Resumen

52. Flynn MP. Human clinical bovine-type brucellosis not derived from milk. Public Health. 1983 May;97(3):149-57. Resumen

53. Kaufmann AF, Fox MD, Boyce JM, et al. Airborne spread of brucellosis. Ann N Y Acad Sci. 1980;353:105-14. Resumen

54. Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis - a sexually transmissible agent? Lancet. 1996 Jun 22;347(9017):1763. Resumen

55. Rabiei MM, Imanzade F, Hatami F, et al. Brucellosis in transplant recipients: a systematic review. Transpl Infect Dis. 2021 Aug;23(4):e13604. Resumen

56. Centers for Disease Control and Prevention; National Center for Emerging and Zoonotic Infectious Diseases. Expansion of the Brucella genus to include Ochrobactrum: clinical considerations. 2022​ [internet publication].Texto completo

57. Gross A, Terraza A, Ouahrani-Bettache S, et al. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect immun. 2000;68:342-351.Texto completo  Resumen

58. de Figueiredo P, Ficht TA, Rice-Ficht A, et al. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015;185:1505-1517.Texto completo  Resumen

59. Khan MY, Mah WM, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis. 2001 Apr 15;32(8):1172-7.Texto completo  Resumen

60. Kurdoglu M, Adali E, Kurdoglu Z, et al. Brucellosis in pregnancy: a 6-year clinical analysis. Arch Gynecol Obstet. 2010 Feb;281(2):201-6. Resumen

61. Paul J, Gilks C, Batchelor B, et al. Serologic responses to brucellosis in HIV-seropositive patients. Trans R Soc Trop Med Hyg. 1995;89:228-230. Resumen

62. Moreno S, Ariza J, Espinosa FJ, et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1998;17:319-326. Resumen

63. Centers for Disease Control and Prevention. Brucellosis reference guide: exposures, testing and prevention. Feb 2017 [internet publication].Texto completo

64. Georghiou PR, Young EJ. Prolonged incubation in brucellosis. Lancet. 1991;337:1543. Resumen

65. Syrjamaki C, Migliazzo A, Yarbrough JW, et al. Brucella abortus endocarditis following ingestion of cow's blood. Nebr Med J. 1984 May;69(5):141-2. Resumen

66. Dadar M, Fakhri Y, Shahali Y, et al. Contamination of milk and dairy products by Brucella species: a global systematic review and meta-analysis. Food Res Int. 2020 Feb;128:108775. Resumen

67. Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun;323(6):299-315. Resumen

68. Pappas G, Panagopoulou P, Christou L, et al. Brucella as a biological weapon. Cell Mol Life Sci. 2006 Oct;63(19-20):2229-36. Resumen

69. Moore TS, Lancaster A, Nelson J, et al. Notes from the field: multidisciplinary approach to investigating Brucella canis exposures - South Carolina, September 2023. MMWR Morb Mortal Wkly Rep. Jun 2024;73:581-2.Texto completo

70. Williams B. Brucellosis. Practitioner. 1982 Sep;226(1371):1507-17. Resumen

71. Gerada A, Beeching NJ. Brucellosis and travel. Travel Med Infect Dis. 2016 May-Jun;14(3):180-1. Resumen

72. Norman FF, Monge-Maillo B, Chamorro-Tojeiro S, et al. Imported brucellosis: a case series and literature review. Travel Med Infect Dis. 2016 May-Jun;14(3):182-99. Resumen

73. Bosilkovski M, Rodriguez-Morales AJ. Brucellosis and its particularities in children travelers. Recent Pat Antiinfect Drug Discov. 2014;9(3):164-72. Resumen

74. Wyatt HV. Brucella melitensis can be transmitted sexually. Lancet. 1996 Aug 31;348(9027):615. [Erratum in: Lancet 1996 Oct 5;348(9032):970.] Resumen

75. Economidou J, Kalafatas P, Vatopolou D, et al. Brucellosis in two thalassaemic patients infected by blood transfusions from the same donor. Acta Haematol. 1976;55(4):244-9. Resumen

76. Martinez-Canseco J, Hernandez-Ramos I, Macias-Hernandez AE, et al. Unjustified disposal of transfusion blood because of antibodies against Brucella [in Spanish]. Rev Invest Clin. 1996 Jul-Aug;48(4):297-300. Resumen

77. World Health Organization. Brucellosis in humans and animals. 2006 [internet publication].Texto completo

78. Luzzi GA, Brindle R, Sockett PN, et al. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):138-41. Resumen

79. UK Health Security Agency. Brucella: laboratory and clinical services. May 2025 [internet publication].Texto completo

80. Robichaud S, Libman M, Behr M, et al. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004 Jun 15;38(12):e119-22.Texto completo  Resumen

81. Mantur BG, Akki AS, Mangalgi SS, et al. Childhood brucellosis - a microbiological, epidemiological and clinical study. J Trop Pediatr. 2004 Jun;50(3):153-7. Resumen

82. Barroso García P, Rodriguez-Contreras Pelayo R, Gil Extremera B, et al. Study of 1,595 brucellosis cases in the Almeria province (1972-1998) based on epidemiological data from disease reporting [in Spanish]. Rev Clin Esp. 2002 Nov;202(11):577-82. Resumen

83. Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929.Texto completo  Resumen

84. Li F, Du L, Zhen H, et al. Follow-up outcomes of asymptomatic brucellosis: a systematic review and meta-analysis. Emerg Microbes Infect. 2023 Dec;12(1):2185464.Texto completo  Resumen

85. Franco MP, Mulder M, Gilman RH, et al. Human brucellosis. Lancet Infect Dis. 2007 Dec;7(12):775-86. Resumen

86. Colomenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore). 1996 Jul;75(4):195-211. [Erratum in: Medicine (Baltimore) 1997 Mar;76(2):139.] Resumen

87. Uddin MJ, Sanyal SC, Mustafa AS, et al. The role of aggressive medical therapy along with early surgical intervention in the cure of Brucella endocarditis. Ann Thorac Cardiovasc Surg. 1998 Aug;4(4):209-13. Resumen

88. Pappas G, Bosilkovski M, Akritidis N, et al. Brucellosis and the respiratory system. Clin Infect Dis. 2003 Oct 1;37(7):e95-9.Texto completo  Resumen

89. Erdem H, Inan A, Elaldi N, et al. Respiratory system involvement in brucellosis: the results of the Kardelen study. Chest. 2014 Jan;145(1):87-94. Resumen

90. Milionis H, Christou L, Elisaf M. Cutaneous manifestations in brucellosis: case report and review of the literature. Infection. 2000 Mar-Apr;28(2):124-6. Resumen

91. Al Dahouk S, Sprague LD, Neubauer H. New developments in the diagnostic procedures for zoonotic brucellosis in humans. Rev Sci Tech. 2013 Apr;32(1):177-88. Resumen

92. Gotuzzo E, Carrilo C, Guerra J, et al. An evaluation of diagnostic methods for brucellosis - the value of bone marrow culture. J Infect Dis. 1986 Jan;153(1):122-5. Resumen

93. Doganay M, Aygen B. Human brucellosis: an overview. Int J Infect Dis. 2003;7:173-82.

94. Yagupsky P. Detection of brucellae in blood cultures. J Clin Microbiol. 1999 Nov;37(11):3437-42.Texto completo  Resumen

95. Gómez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008 Jun;15(6):1031-3.Texto completo  Resumen

96. Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, et al. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005 Mar;11(3):221-5. Resumen

97. Araj GF, Lulu AR, Mustafa MY, et al. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J Hyg (Lond). 1986 Dec;97(3):457-69. Resumen

98. Abdoel TH, Smits HL. Rapid latex agglutination test for the serodiagnosis of human brucellosis. Diagn Microbiol Infect Dis. 2007 Feb;57(2):123-8. Resumen

99. Nielson K, Smith P, Widdison J, et al. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7. Vet Microbiol. 2004 May 20;100(1-2):25-30. Resumen

100. Ariza J, Pellicer T, Pallares R, et al. Specific antibody profile in human brucellosis. Clin Infect Dis. 1992 Jan;14(1):131-40. Resumen

101. Lucero NE, Escobar GI, Ayala SM, et al. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol. 2005 May;54(Pt 5):457-61.Texto completo  Resumen

102. Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004 Sep 3;22(25-26):3435-9. Resumen

103. Queipo-Ortuño MI, Morata P, Ocón P, et al. Rapid diagnosis of human brucellosis by peripheral-blood PCR assay. J Clin Microbiol. 1997 Nov;35(11):2927-30.Texto completo  Resumen

104. Mitka S, Anetakis C, Souliou E, et al. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol. 2007 Apr;45(4):1211-8.Texto completo  Resumen

105. Vrioni G, Pappas G, Priavali E, et al. An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis. 2008 Jun 15;46(12):e131-6.Texto completo  Resumen

106. Lista F, Reubsaet FA, De Santis R, et al. Reliable identification at the species level of Brucella isolates with MALDI-TOF-MS. BMC Microbiol. 2011 Dec 23;11:267.Texto completo  Resumen

107. Ferreira L, Vega Castaño S, Sánchez-Juanes F, et al. Identification of Brucella by MALDI-TOF mass spectrometry: fast and reliable identification from agar plates and blood cultures. PLoS One. 2010 Dec 6;5(12):e14235.Texto completo  Resumen

108. Karger A, Melzer F, Timke M, et al. Interlaboratory comparison of intact-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry results for identification and differentiation of Brucella spp. J Clin Microbiol. 2013 Sep;51(9):3123-6.Texto completo  Resumen

109. Araj GF, Lulu AR, Khateeb MI, et al. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. APMIS. 1988 Feb;96(2):171-6. Resumen

110. Erdem H, Kilic S, Sener B, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect. 2013 Feb;19(2):E80-6. Resumen

111. Yagupsky P, Peled N. Use of the Isolator 1.5 microbial tube for detection of Brucella melitensis in synovial fluid. J Clin Microbiol. 2002 Oct;40(10):3878.Texto completo  Resumen

112. Kokoglu OF, Hosoglu S, Geyik MF, et al. Clinical and laboratory features of brucellosis in two university hospitals in Southeast Turkey. Trop Doct. 2006 Jan;36(1):49-51. Resumen

113. Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore). 2005 May;84(3):174-87. Resumen

114. Mohamed MFH, Ahmed AOE, Habib MB, et al. The prevalence of the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in brucellosis patients: systematic review and meta-analysis. Ann Med Surg (Lond). 2022 Feb;74:103340.Texto completo  Resumen

115. Al-Shahed MS, Sharif HS, Haddad MC, et al. Imaging features of musculoskeletal brucellosis. Radiographics. 1994 Mar;14(2):333-48. Resumen

116. Pourbagher A, Pourbagher MA, Savas L, et al. Epidemiologic, clinical, and imaging findings in brucellosis patients with osteoarticular involvement. AJR Am J Roentgenol. 2006 Oct;187(4):873-80.Texto completo  Resumen

117. Akkoc G, Tekerek S. Osteoarticular involvement in childhood brucellosis: evaluation of clinical, laboratory and radiologic features of 185 cases. Pediatr Infect Dis J. 2023 May 1;42(5):381-8. Resumen

118. Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect. 2014 Nov;20(11):O847-53.Texto completo  Resumen

119. Richman JA, Gelberman RH, Engber WD, et al. Ganglions of the wrist and digits: results of treatment by aspiration and cyst wall puncture. J Hand Surg Am. 1987 Nov;12(6):1041-3. Resumen

120. Dhar D, Jaipuriar RS, Mondal MS, et al. Pediatric neurobrucellosis: a systematic review with case report. J Trop Pediatr. 2022 Dec 5;69(1). Resumen

121. Xu N, Qu C, Sai L, et al. Evaluating the efficacy of serological testing of clinical specimens collected from patients with suspected brucellosis. PLoS Negl Trop Dis. 2023 Feb;17(2):e0011131.Texto completo  Resumen

122. Centers for Disease Control and Prevention. Brucellosis (Brucella spp.) 2010 case definition. 2010 [internet publication].Texto completo

123. Rusnak JM, Kortepeter MG, Aldis J, et al. Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). J Occup Environ Med. 2004 Aug;46(8):801-11. Resumen

124. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997 Apr-Jun;3(2):213-21.Texto completo  Resumen

125. Brown CE, Beeching NJ, Cooke RP. Laboratory acquired brucellosis - a review of published reports 1950-2007. Posters, 18th ECCMID, abstract P1852. Clin Microbiol Infect. 2008;14(suppl 7):S542.Texto completo

126. Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007 Dec;4(12):e317.Texto completo  Resumen

127. Skalsky K, Yahav D, Bishara J, et al. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008 Mar 29;336(7646):701-4.Texto completo  Resumen

128. Solís García del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One. 2012;7(2):e32090.Texto completo  Resumen

129. Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, et al. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007179.Texto completo  Resumen

130. Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012 Apr;16(4):e247-51. Resumen

131. Pappas G, Christou L, Akritidis N, et al. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect. 2006 Sep;12(9):823-5. Resumen

132. Bosilkovski M, Kirova V, Grozdanovski K, et al. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis. Trop Doct. 2012 Jan;42(1):13-7. Resumen

133. Vrioni G, Bourdakis A, Pappas G, et al. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Antimicrob Agents Chemother. 2014 Dec;58(12):7541-4.Texto completo  Resumen

134. Keshtkar-Jahromi M, Razavi SM, Gholamin S, et al. Medical versus medical and surgical treatment for brucella endocarditis. Ann Thorac Surg. 2012 Dec;94(6):2141-6. Resumen

135. Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev Anti Infect Ther. 2007 Dec;5(6):983-90. Resumen

136. Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012 Mar;56(3):1523-8.Texto completo  Resumen

137. Tajerian A, Sofian M, Zarinfar N, et al. Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis. Int J Neurosci. 2022 Aug 5 [Epub ahead of print].Texto completo  Resumen

138. Ulu-Kilic A, Karakas A, Erdem H, et al. Update on treatment options for spinal brucellosis. Clin Microbiol Infect. 2014 Feb;20(2):O75-82. Resumen

139. Salehi M, Farbod F, Khalili H, et al. Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial. J Antimicrob Chemother. 2023 Apr 3;78(4):1084-91. Resumen

140. Majzoobi MM, Hashemi SH, Mamani M, et al. Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trial. Int J Antimicrob Agents. 2018 Mar;51(3):365-9. Resumen

141. Majzoobi MM, Hashmi SH, Emami K, et al. Combination of doxycycline, streptomycin and hydroxychloroquine for short-course treatment of brucellosis: a single-blind randomized clinical trial. Infection. 2022 Oct;50(5):1267-71.Texto completo  Resumen

142. Centers for Disease Control and Prevention (CDC). Suspected brucellosis case prompts investigation of possible bioterrorism-related activity - New Hampshire and Massachusetts, 1999. MMWR Morb Mortal Weekly Rep. 2000 Jun 16;49(23):509-12.Texto completo  Resumen